The role of G protein-coupled receptor Frizzled2 in tumor.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 924, doi. 10.3872/j.issn.1007-385X.2024.09.012
- Publication type:
- Article
Works matching IS 1007385X AND DT 2024 AND VI 31 AND IP 9
Results: 14
1
2
Tumor immunotherapy with mesothelin-targeted drugs: opportunities and challenges.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 841, doi. 10.3872/j.issn.1007-385X.2024.09.001
- By:
- Publication type:
- Article
3
Development of a job competency-oriented graduate laboratory course of tumor immunology.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 937, doi. 10.3872/j.issn.1007-385X.2024.09.014
- Publication type:
- Article
4
Progress in targeting the Wnt/β-catenin signaling pathway for the treatment of cervical cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 931, doi. 10.3872/j.issn.1007-385X.2024.09.013
- Publication type:
- Article
5
Progress in the mechanism of T-cell exhaustion in multiple myeloma and its significance.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 918, doi. 10.3872/j.issn.1007-385X.2024.09.011
- Publication type:
- Article
6
Progress in the potential immunotherapy target Fli-1.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 913, doi. 10.3872/j.issn.1007-385X.2024.09.010
- Publication type:
- Article
7
Clinical efficacy and safety of tumor-specific individualized multi-target DC-CIK therapy for primary liver cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 907, doi. 10.3872/j.issn.1007-385X.2024.09.009
- By:
- Publication type:
- Article
8
Expression of CCT subunits in thyroid cancer and their impacts on clinical prognosis, tumor microenvironment and chemotherapy drug sensitivity of patients.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 895, doi. 10.3872/j.issn.1007-385X.2024.09.008
- By:
- Publication type:
- Article
9
Expression of ILC2s, MDSCs and associated cytokines IL-13, iNOS in cervical cancer and construction and evaluation of a nomogram model.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 878, doi. 10.3872/j.issn.1007-385X.2024.09.006
- By:
- Publication type:
- Article
10
The expression and clinicopathological significance of structural maintenance of chromosome 4 in breast cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 888, doi. 10.3872/j.issn.1007-385X.2024.09.007
- By:
- Publication type:
- Article
11
The effects and possible mechanisms of SRSF7 on the proliferation, migration, and invasion of HepG2 cells.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 864, doi. 10.3872/j.issn.1007-385X.2024.09.004
- By:
- Publication type:
- Article
12
Germacrone reguates proliferation, migration and chemoresistance of thyroid cancer BCPAP cells through FOXO3-FOXM1 axis.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 871, doi. 10.3872/j.issn.1007-385X.2024.09.005
- By:
- Publication type:
- Article
13
Effects of MET knockdown on proliferation, migration and sensitivity to 5-FU and cisplatin of laryngeal cancer Hep-2 cells.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 857, doi. 10.3872/j.issn.1007-385X.2024.09.003
- By:
- Publication type:
- Article
14
Synthesis and identification of RGD-modified tumstatin peptide 19 and its inhibitory effect on proliferation, migration, and invasion of liver cancer SK-Hep-1 cells.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 849, doi. 10.3872/j.issn.1007-385X.2024.09.002
- By:
- Publication type:
- Article